Literature DB >> 10839330

Decisional capacity for informed consent in schizophrenia research.

W T Carpenter1, J M Gold, A C Lahti, C A Queern, R R Conley, J J Bartko, J Kovnick, P S Appelbaum.   

Abstract

BACKGROUND: The adequacy of subjects' informed consent to research is the focus of an important public and professional debate. The potential impairment of decisional capacity in persons with schizophrenia is central to the discussions. This study ascertains the decisional capacity for informed consent in schizophrenic research subjects, to determine if reduced capacity relates to specific aspects of psychopathologic features and to test the hypothesis that reduced capacity can be remediated with an educational informed consent process.
METHODS: Decisional capacity was assessed for 30 research subjects with schizophrenia and 24 nonill (normal) comparison subjects. Measures of psychopathologic features and cognition were obtained for the subjects with schizophrenia. Subjects who performed poorly on the decisional capacity measure received an educational intervention designed to improve their ability to provide informed consent and were then retested.
RESULTS: The patient group did not perform as well as the controls on initial decisional capacity assessment. Poor performance was modestly related to the extent of symptoms but robustly related to cognitive impairments. Following the educational intervention, the performance of subjects with schizophrenia was equal to that of the nonill comparison group.
CONCLUSIONS: Many persons with schizophrenia may be challenged by the cognitive demands of an informed consent process for research participation. In many cases, their reduced capacity can be compensated by a more intensive educational intervention as part of the informed consent process.

Entities:  

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies

Mesh:

Year:  2000        PMID: 10839330     DOI: 10.1001/archpsyc.57.6.533

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  134 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Screening for understanding of research in the inpatient psychiatry setting.

Authors:  Norval J Hickman; Judith J Prochaska; Laura B Dunn
Journal:  J Empir Res Hum Res Ethics       Date:  2011-09       Impact factor: 1.742

Review 3.  Ethical considerations in psychopharmacological research involving decisionally impaired subjects.

Authors:  Donald L Rosenstein; Franklin G Miller
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

Review 4.  Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies.

Authors:  Ellen Frank; Danielle M Novick; David J Kupfer
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

5.  [Mental competence and neuropsychologic impairments in demented patients].

Authors:  J Vollmann; K-P Kühl; A Tilmann; H D Hartung; H Helmchen
Journal:  Nervenarzt       Date:  2003-05-10       Impact factor: 1.214

6.  End-of-life care and mental illness: a model for community psychiatry and beyond.

Authors:  Philip J Candilis; Mary Ellen G Foti; Jacob C Holzer
Journal:  Community Ment Health J       Date:  2004-02

7.  Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Authors:  Michael R Basso; Philip J Candilis; Jay Johnson; Courtney Ghormley; Dennis R Combs; Taeh Ward
Journal:  J Clin Exp Neuropsychol       Date:  2010-12       Impact factor: 2.475

8.  Picturing neuroscience research through a human rights lens: imaging first-episode schizophrenic treatment-naive individuals.

Authors:  Marleen Eijkholt; James A Anderson; Judy Illes
Journal:  Int J Law Psychiatry       Date:  2012-02-02

9.  Emergency Department Use in a Cohort of Older Homeless Adults: Results From the HOPE HOME Study.

Authors:  Maria C Raven; Lina Tieu; Christopher T Lee; Claudia Ponath; David Guzman; Margot Kushel
Journal:  Acad Emerg Med       Date:  2017-01       Impact factor: 3.451

10.  Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment.

Authors:  Barton W Palmer; Kerry A Ryan; H Myra Kim; Jason H Karlawish; Paul S Appelbaum; Scott Y H Kim
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-11       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.